Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Immunotargets and Therapy|April 28, 2021
TNFR2: Role in Cancer Immunology and ImmunotherapyYang Yang, Md Sahidul Islam, Yuanjia Hu, et al.
Plos One|November 14, 2013
Is the United States still dominant in the global pharmaceutical innovation network?Yuanjia Hu, Thomas Scherngell, Si Nga Man, et al.
Discover Oncology|August 21, 2023
A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.govJing Yang, Heming Kang, Liyang Lyu, et al.
Antioxidants (Basel, Switzerland)|September 28, 2023
Association between the Composite Dietary Antioxidant Index and Atherosclerotic Cardiovascular Disease in Postmenopausal Women: A Cross-Sectional Study of NHANES Data, 2013-2018Chenning Liu, Wenyu Lai, Meiduo Zhao, et al.
BMC Infectious Diseases|March 5, 2022
Investigating the intention to receive the COVID-19 vaccination in Macao: implications for vaccination strategiesCarolina Oi Lam Ung, Yuanjia Hu, Hao Hu, et al.
International Journal for Parasitology. Parasites and Wildlife|August 14, 2025
Molecular identification of the potential fifth species within genus <i>Hydatigera</i> (Cestoda: Taeniidae) in rodents of Guangdong province, ChinaJiang Rao, Xinyuan Cui, Yiwen Gao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 5, 2015
China's landscape in oncology drug research: perspectives from research collaboration networksHan You, Jingyun Ni, Michael Barber, et al.
Frontiers in Immunology|April 11, 2018
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological AgentsHuimin Zou, Ruixin Li, Hao Hu, et al.
Mabs|September 18, 2025
Exploring the nanobody patent landscape: a focus on BCMA sequences and structural analysisJiaqi Xu, Yan Wang, Ni Yuan, et al.
Chinese Medicine|April 1, 2016
Analyzing the Chinese landscape in anti-diabetic drug research: leading knowledge production institutions and thematic communitiesJunling Deng, Kaweng Sitou, Yongping Zhang, et al.
Pageof 13